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The aim of this in vitro study was to evaluate the effects of monolaurin against
Aggregatibacter actinomycetemcomitans (Aa) and determine their effects on the host
transcriptome and metabolome, using an oral cell/bacteria co-culture dual-chamber
model to mimic the human periodontium. For this, the Aa, was applied to cross the
monolayer of epithelial keratinocytes (OBA-9) to reach the fibroblasts layer (HGF-1) in
the basal chamber. The Monolaurin treatments (25 or 50 µM) were added immediately
after the inoculation of the dual-chamber with Aa. After 24 h, the transcriptional factors
and metabolites produced were quantified in the remaining cell layers (insert and basal
chamber) and in supernatant released from the cells. The genes IL-1α, IL-6, IL-18,
and TNF analyzed in HGF-1 concentrations showed a decreased expression when
treated with both concentration of Monolaurin. In keratinocytes, the genes IL-6, IL-
18, and TNF presented a higher expression and the expression of IL-1α decreased
when treated with the two cited concentrations. The production of glycerol and
pyruvic acid increased, and the 2-deoxytetronic acid NIST, 4-aminobutyric acid, pinitol
and glyceric acid, presented lower concentrations because of the treatment with 25
and/or 50 µM of Monolaurin. Use of monolaurin modulated the immune response and
metabolite production when administered for 24 h in a dual-chamber model inoculated
with A. actinomycetemcomitans. In summary, this study indicates that monolaurin
had antimicrobial activity and modulated the host immune response and metabolite
production when administered for 24 h in a dual-chamber model inoculated with
A. actinomycetemcomitans.
Keywords: Aggregatibacter actinomycetemcomitans, periodontal disease, immune system, fibroblast,
keratinocyte, monolaurin
INTRODUCTION
Periodontal disease is characterized by bacterial infection associated with the presence of biofilm,
resulting in chronic inflammation of the tooth supporting tissues leading to a progressive
destruction of periodontal tissue and alveolar bone. Signs and symptoms of periodontitis can
include gingival swelling, bleeding during brushing, periodontal pockets, increased spacing
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between the teeth and tooth loss (Irfan et al., 2001; Michaud et al.,
2007; Savage et al., 2009; Gurav, 2014).
The most common form of periodontal disease, denominated
periodontitis, affects approximately 50% of the adult population
with its severe forms affecting 10–15% of these individuals
(Chapple and Genco, 2013).
The oral biofilm is composed of at least 800 different species
of bacteria (Paster et al., 2006; Filoche et al., 2010). Numerous
periodontopathogenic bacteria (Porphyromonas gingivalis,
Fusobacterium nucleatum, Streptococcus intermedius, and others)
are responsible for the initiation and maintenance of periodontal
inflammation (Coussens and Werb, 2002; Oringer, 2002;
Loos, 2005; Moutsopoulos and Madianos, 2006; de Almeida
et al., 2007). The Aggregatibacter actinomycetemcomitans is a
fermentative, gram-negative and capnophilic coccobacillus. It
is not only considered the most important agent of localized
aggressive periodontitis lesions, but is associated with chronic
periodontitis as well (Slots et al., 1980; Zambon et al., 1983;
Haraszthy et al., 2000; Gafan et al., 2004; Yang et al., 2004;
Cortelli et al., 2009; Rakić et al., 2010; da Silva-Boghossian
et al., 2011). The progression of periodontal disease is associated
with the virulence factors of the microorganism, together
with the vulnerability of the host. Aa produces leukotoxin,
adhesins, bacteriocins, and lipopolysaccharide, which are
responsible for interacting with the host cells triggering
an inflammatory response in the periodontium (Cortelli
et al., 2009). In addition, another critical factor for soft
tissue inflammation and bone resorption is the immune-
inflammatory host response to the bacterial biofilm (Salvi and
Lang, 2005).
According to Aimetti (2014), non-surgical periodontal
treatments possess limitations, such as the long-term
maintainability of deep periodontal pockets, risk of disease
recurrence, and skill of the operator. The development of
new therapeutic agents that have the ability to inhibit the
biofilm formation and modulate the inflammatory response
can have a major impact in the prevention and treatment
of periodontal disease. Monolaurin, also known as glycerol
monolaurate or lauroyl, is a natural surfactant compound
commonly used in cosmetics and the food industry. It is
recognized by the Food and Drug Administration (FDA) as
a GRAS (Generally Recognized as Safe) food additive since
1977. This natural compound is found in coconut oil and
human breast milk (Fu et al., 2006; Peterson and Schlievert,
2006).
Monolaurin presents antibacterial and antiviral activity
in vitro (Projan et al., 1994; Isaacs, 2001; Preuss et al.,
2005; Peterson and Schlievert, 2006; Carpo et al., 2007),
which may be of great interest in the treatment and/or
prevention of various infections. However, the effect of
monolaurin on periodontopathogenic bacteria has yet to be
determined.
Therefore, the aims of this in vitro study were to evaluate
the cytotoxicity, the antimicrobial effect of monolaurin against
A. actinomycetemcomitans and to determine its effect on the




For carrying out the experiments, the monolaurin utilized
was 1-lauroyl-rac-glycerol (Sigma-Aldrich, St. Louis, MO,
United States). For dilution, sterilized deionized water was used
as the vehicle.
Cells and Bacterial Strain
Human gingival fibroblast – HGF-1 (ATCC R© CRL-2014) were
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)
(Lonza, Walkersville, MD, United States) with 10% Fetal Bovine
Serum (FBS) (Lonza, Walkersville, MD, United States). Human
gingival epithelial cells (keratinocyte OBA-9) were cultured in
specific medium for keratinocytes, Defined Keratinocyte-SFM
(Life Technologies, Carlsbad, CA, United States) (Oda and
Watson, 1990; Kusumoto et al., 2004).
Aggregatibacter actinomycetemcomitans (strain D7S-1)
was cultivated from a subgingival plaque from an African-
American female patient diagnosed with generalized aggressive
periodontitis (Chen et al., 2010). The bacteria were grown in
Trypticase Soy Broth (TSB) (Becton Dickinson, Franklin Lakes,
NJ, United States).
Antimicrobial Activity
Monolaurin antimicrobial activity was evaluated in
A. actinomycetemcomitans after 24 h of treatment. Micro-
organisms were inoculated [1 × 106 colony-forming unit per
milliliter (CFU/mL) in a 96-well microtiter plate with TSB
(Becton Dickinson, Franklin Lakes, NJ, United States)] and
monolaurin was immediately added in various concentrations
(0.5–1,000 µM) to determine the minimum inhibitory
concentration (MIC) (Branco-de-Almeida et al., 2011).
Microplates were maintained in a humidified incubator at
37◦C and 5% CO2. After incubation, bacterial growth was
assayed by measurement of absorbance at 660 nm. MIC was
defined as the lowest concentration of monolaurin that had
restricted growth to a level, 0.05 at 660 nm (no visible growth).
Cytotoxicity Assay
In vitro cytotoxicity effect was measured by the fluorometric
resazurin method (O’Brien et al., 2000). OBA-9 or HGF-1
cells were seeded (1 × 105 cells/mL) in 96-well microtiter
plates and maintained in a humidified incubator at 37◦C and
5% CO2. After 24 h, cell morphology was observed under an
inverted microscope (EVOS FL Life Technologies, Carlsbad,
CA, United States) to confirm that they had adhered to the
bottom of each well and were presenting proper morphology.
The monolaurin (0.5–1,000 µM) was added to the cell cultures
and incubated at 37◦C and 5% CO2. After 24 h, the medium
was discarded, cells were washed with room temperature
phosphate buffered saline (PBS) (Lonza, Walkersville, MD,
United States), and fresh, room temperature medium was
added with resazurin (Cell Titer Blue Viability Assay – Promega
Corp., Madison, WI, United States). Subsequently, the plate
was incubated at 37◦C and 5% CO2. After 4 h, the contents
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of the wells were transferred to a new microplate and the
fluorescence was read in a microplate reader (SpectraMax
M5, Molecular Devices, Sunnyvale, CA, United States)
with excitation 550 nm, emission 585 nm, and cut off
570 nm (Pasetto et al., 2014). To calculate the results and
obtain the LD50 (Lethal Dose), we performed a non-linear
regression the program MasterPlex ReaderFit (Hitachi Solutions
America).
Dual-Chamber Model
A dual-chamber, oral cell/bacteria co-culture was used to
investigate the immunological effects of monolaurin (Silva et al.,
2017). HGF-1 cells (1 × 105) were seed in the basal chamber of a
24-well plate. Transwell inserts (8 µm pore × 0.3 cm2 of culture
surface – Greiner Bio-One, Monroe, NC, United States) were
positioned in each well and OBA-9 cells (1 × 105) were seeded
into the inserts. DMEM (Lonza, Walkersville, MD, United States)
with 10% FBS (Lonza, Walkersville, MD, United States) was
used for the medium. The plates were incubated at 37◦C in
humid air containing 5% CO2 for 24 h (Silva et al., 2017).
Trans Epithelial Electric Resistance (TEER) of each cell layer
was measured with a Millicell-ERS Volt-Ohm Meter (Millipore,
Bedford, MA, United States). Cell layer confluence in the
Transwell insert was measured daily until reaching optimal
TEER (>150 Ohm/cm2) after 48 h. Once reaching optimal
TEER, the media of the basal chamber and the insert were
replaced with new media containing A. actinomycetemcomitans
(1 × 106 CFU/mL). Medium containing the microorganism
was added to the insert, passing through the upper layer of
cells (OBA-9) and reaching the bottom cell layer (HGF-1).
Immediately after the inoculation of oral cell/bacteria co-culture
with A. actinomycetemcomitans the monolaurin treatments (25
and 50 µM) were added and the plate was incubated at 37◦C
in humid air containing 5% CO2. The time of exposure of the
microorganism to monolaurin was 24 h. Each experiment was
repeated three times with two replicates per group (n = 6).
The experiment was divided in three groups: (1) Control – oral
cell/bacteria co-culture with Aa inoculated and no treatment;
(2) Mono 25 – oral cell/bacteria co-culture with Aa inoculated
and treated with 25 µM of monolaurin; (3) Mono 50 – oral
cell/bacteria co-culture with Aa inoculated and treated with
50 µM of monolaurin.
Collecting Samples for Analysis
After the treatment period, liquid contents from each well was
collected and centrifuged at 1,200 rpm for 10 min. Following
centrifugation, supernatant was divided into two aliquots for
enzyme-linked immunosorbent assay (ELISA) and metabolome
analysis. RNA was isolated from the remaining cell layers of HGF-
1 and OBA-9 (surface of the wells and inserts) for gene analysis in
quantitative real-time PCR.
ELISA Assay
Inflammatory cytokines were determined using a commercial
ELISA (Multi-Analyte ELISArray – Qiagen, Valencia, CA,
United States). The cytokines were measured by standard ELISA
protocol using a panel of 12 inflammatory cytokines: interleukin-
1 alpha (IL-1α), interleukin-1 beta (IL-1β), interleukin-2 (IL-
2), interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-8 (IL-
8), interleukin-10 (IL-10), interleukin-12 (IL-12), interleukin-17
alpha (IL-17α), interferon gamma (IFNγ), tumor necrosis factor
alpha (TNFα), Granulocyte-Macrophage Colony Stimulating
Factor (GM-CSF). Cytokines that presented the greatest change
in concentration were selected for detailed analysis. These
cytokines were analyzed using a standard ELISA protocol (Single
Analyte ELISA Kit – Qiagen, Valencia, CA, United States).
Gene Expression – Quantitative
Real-Time PCR
Total RNA was extracted through a commercial RNA purification
kit (Mini Kit Qiagen RNeasy Protocol – Qiagen, Valencia, CA,
United States) and the purity and quantity were measured
in a NanoPhotometer P360 (Implen, Westlake Village,
CA, United States). Total RNA was converted into single-
stranded cDNA using a high-capacity reverse transcription
kit (QuantiTec Reverse Transcription Kit – Qiagen, Valencia,
CA, United States). An array for evaluation of gene expression
of the inflammatory response was completed by quantitative
real-time PCR (Prime PCR Pathway Plate/Acute Inflammation
Response – Bio-Rad, Hercules, CA, United States) from the
cDNA obtained. Based on these results, six genes/primers
were selected for detailed study: interleukin 1 alpha (IL-1α),
interleukin 6 (IL-6), interleukin 18 (IL-18), caspase 3 (CASP3),
matrix metallopeptidase 1 (MMP-1), and tumor necrosis factor
(TNF) (QuantiTect Primer Assay – Qiagen, Valencia, CA,
United States). QuantiTect SYBR Green PCR Kits (Qiagen,
Valencia, CA, United States) were used to determine the gene
expression of the selected primers. The reaction product was
quantified by relative quantification using Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) as the reference gene.
Data were analyzed as fold-change compared to control.
The cycle threshold was calculated and interpreted using
CFX Connect (Bio-Rad, Hercules, CA, United States) (Pfaffl,
2001).
Metabolome Analysis
Samples for metabolome analysis were treated as described by
Silva et al. (2017) and analyzed at the West Coast Metabolomics
Center (UC Davis Genome Center, Davis, CA, United States) by
means of gas chromatography/mass spectrometry (Agilent 6890,
Santa Clara, CA/Leco Pegasus IV, St. Joseph, MI, United States).
Then, the metabolites were compared with the standard library
for proper identification (Fiehn and Kind, 2007).
Statistical Analysis
Data were expressed as mean ± standard deviation. The
comparison between the groups was made through analysis
of variance (ANOVA) and when a difference was determined,
the Bonferroni test was applied. Data were analyzed using
GraphPad Prism (version 5.01, GraphPad Software, San
Diego, United States). The level of significance was set at
p < 0.05.
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RESULTS
Antimicrobial Activity and Cytotoxicity
Assay
In order to determine antimicrobial activity of monolaurin, a
range of 0.5–1,000 µM was tested. Antibacterial activity was
detected at 25–50 µM. The minimum inhibitory concentration
(MIC) was established between 25 and 50 µM. The cytotoxicity
assays were conducted in HGF-1 and OBA-9 cells and the
results are shown in Figure 1. For HGF-1 the LD50 was
146 µM of monolaurin and for OBA-9 the LD50 was 69 µM of
monolaurin.
ELISA
Enzyme-linked immunosorbent assay (ELISA) results are
presented in Figure 2. Both treatments (25 and 50 µM) of
monolaurin increased the concentrations of GM-CSF and IL-1α.
The concentrations of IL-6 and IL-10 increased only with the
50 µM treatment. On the other hand, IL-1β decreased as a
function of monolaurin.
FIGURE 1 | Cytotoxicity assay of cells treated with different doses of
monolaurin in an oral cell/bacteria co-culture inoculated with
A. actinomycetemcomitans: (A) HGF-1 cell (fibroblasts); (B) OBA-9 cell
(keratinocytes). Cell viability was presented in percentage (%) ± standard
deviation. Control group = 100% viability, n = 6. Non-treated cells were
considered as 100% viability; DMSO was used as positive control to
demonstrate an appropriate system-cell response (100% cytotoxicity – data
not shown).
FIGURE 2 | Percent concentrations of GM-CSF, IL-1α, IL-1-β, IL-6, and IL-10
by ELISA, obtained from cell culture supernatant. Oral cell co-culture
inoculated with A. actinomycetemcomitans and treated with 25 µM of
monolaurin (Mono 25) or 50 µM of monolaurin (Mono 50) compared with the
control group. Control group is oral cell co-culture inoculated with
A. actinomycetemcomitans and no treatment. The control group mean is
expressed as 100% and treated groups have their mean relative to the control
group. Mean ± standard deviation; n = 4.
Gene Expression – Quantitative
Real-Time PCR
Quantitative real-time PCR results are presented in Figures 3, 4.
The genes IL-1α, IL-6, IL-18, and TNF analyzed in HGF-1 showed
a decreased expression (p < 0.05) when treated with 25 or 50 µM
of monolaurin compared with group Control (Figures 3A–C,F).
CASP3 and MMP-1 genes showed no difference (Figures 3D,E).
Keratinocytes presented a higher IL-6, IL-18, and TNF gene
expression (p < 0.05) when treated with 25 or 50 µM of
monolaurin compared with the control group (Figures 4B,C,F).
IL-1α gene decreased expression (p < 0.05) in the group treated
with both concentrations (Figure 4A). CASP-3 and MMP-1 genes
showed no difference (Figures 4D,E).
Metabolome
The metabolome study returned a total of 283 metabolites.
Of these, 120 were identified and only 6 presented a
statistical difference as a function of monolaurin treatment.
Some metabolites presented significantly altered concentrations
(Figure 5). It was observed that both treatments of monolaurin
increased the production of glycerol (Figure 5D) and pyruvic
acid (Figure 5F) when compared to control. On the other hand,
the 2-deoxytetronic acid NIST (Figure 5A) showed the opposite
result, lower concentrations of this metabolite, in function of
the treatment with 25 and 50 µM of monolaurin. The 50 µM
monolaurin treatment group presented lower concentrations of
4-aminobutyric acid (Figure 5B), glyceric acid (Figure 5C), and
pinitol (Figure 5E), against the control group.
DISCUSSION
Periodontal disease is known to be a widespread oral health
problem across the world. Several methods for prevention and
treatment of oral diseases have been used over time and new
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FIGURE 3 | Relative expression of genes from HGF-1 cells (fibroblasts) by quantitative PCR: (A) IL-1α; (B) IL-6; (C) IL-18; (D) CASP3; (E) MMP-1; (F) TNF. Oral
cell/bacteria co-culture inoculated with A. actinomycetemcomitans and treated with different doses of monolaurin (25 µM – Mono 25 or 50 µM – Mono 50). Control
group is oral cell co-culture inoculated with A. actinomycetemcomitans and no treatment. The control group has their mean expressed equal to 1 and treated groups
have their mean relative to the control group. Different letters (a, b, and c) indicate statistical difference between groups. The results were expressed by
mean ± standard deviation; n = 6 and p < 0.05.
FIGURE 4 | Relative expression of genes from OBA-9 cells (keratinocytes) by quantitative PCR: (A) IL-1α; (B) IL-6; (C) IL-18; (D) CASP3; (E) MMP-1; (F) TNF. Oral
cell/bacteria co-culture inoculated with A. actinomycetemcomitans and treated with different doses of monolaurin (25 µM – Mono 25 or 50 µM – Mono 50). Control
group is oral cell co-culture inoculated with A. actinomycetemcomitans and no treatment. The control group has their mean expressed equal to 1 and treated groups
have their mean relative to the control group. Different letters (a, b, and c) indicate statistical difference between groups. The results were expressed by
mean ± standard deviation; n = 6 and p < 0.05.
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FIGURE 5 | Metabolites obtained from cell culture supernatant (HGF-1 and
OBA-9 co-culture cells): (A) 2-deoxytetronic acid NIST; (B) 4-aminobutyric
acid; (C) glyceric acid; (D) glycerol; (E) pinitol; (F) pyruvic acid. Oral
cell/bacteria co-culture model inoculated with A. actinomycetemcomitans and
treated with different doses of monolaurin (25 µM – Mono 25 or 50 µM –
Mono 50). Control group is oral cell co-culture inoculated with
A. actinomycetemcomitans and no treatment. Different letters (a, b, and c)
indicate statistical difference between groups. The data is expressed in relative
peak heights (mAU) from HPLCMS analysis, which are unitless
(mean ± standard deviation); n = 4 and p < 0.05.
technologies are being developed. However, little attention has
been given to the understanding of how periodontal structures
are affected and how these structures react to different types of
treatments (Balloni et al., 2016). Currently, some mouthwashes
and toothpastes have been used as topical antimicrobial agents
(Barnett, 2003). However, monolaurin is not listed as an active
ingredient in commercially available mouthwashes. Monolaurin
has been shown to possess diverse biological activities, such
as antibacterial and antiviral properties (Preuss et al., 2005;
Li et al., 2009; Tangwatcharin and Khopaibool, 2012; Seleem
et al., 2016). In our in vitro study, susceptibility assays of
monolaurin showed inhibition of microorganism grow at 25–
50 µM with minimal cytotoxicity. The putative pathways
by which monolaurin affects Aa may involve: (i) increased
membrane permeability and cell lysis, (ii) disruption of electron
transport chain and uncoupling oxidative phosphorylation, and
(iii) inhibition of membrane enzymatic activities and nutrient
uptake (Yoon et al., 2018). In addition, co-culture supernatant
were assessed for expression of host pro-inflammatory cytokines,
gene expression of inflammatory cytokines and metabolomic
profile in human cells infected with A. actinomycetemcomitans.
The gingival tissue comprises the oral epithelium and
superficial underlying connective tissue. These tissues are sites of
initiation for inflammatory processes and the first to be affected
by biofilm (Balloni et al., 2016). Gingival epithelial cells represent
a physical barrier against bacteria and are involved in processes of
innate immunity (Jang et al., 2015). Keratinocytes and fibroblasts
represent the major cell types present in gingival epithelial tissues.
They interact directly with pathogenic microorganisms and are
able to express a variety of cytokines and chemokines such as IL-
1α, IL-6, IL-8, TNF, among others (Bodet et al., 2007; Groeger
and Meyle, 2015). In the present study, there was a decrease in
the gene expression of IL-1α, IL-6, and IL-18 and TNF in HGF-1
and an increase in the expression of IL-6, IL-18, and TNF in OBA-
9 cells treated with monolaurin indicating a positive modulation
in the inflammatory response of these cells.
Interleukin-1 alpha is a polypeptide that plays several roles in
tissue homeostasis, immunity and has a proinflammatory nature.
It is produced mainly by macrophages and monocytes, but also
epithelial cells and fibroblasts (Champagne et al., 2003; Balloni
et al., 2016). IL-1α plays a critical role in protecting the body
against invaders, such as bacteria and viruses, and is involved
in extracellular matrix and bone metabolism (bone resorption,
disintegration, and removal of bone tissue that is no longer
needed). Therefore, IL-1α is considered a marker of periodontal
disease (Govindarajan et al., 2015; Groeger and Meyle, 2015).
Here, we observed a decrease in the expression of IL-1α
by HGF-1 and OBA-9 cells in the monolaurin-treated groups
which may be related to a beneficial inflammatory response since,
elevated levels of IL-1α and IL-1β in the gingival crevicular
fluid are commonly found in patients with periodontal disease.
This increased production of IL-1 is associated with a higher
inflammatory response to the bacterial stimulus, resulting in
more severe disease as well as an unfavorable response to
treatments (Kornman et al., 1997; Engebretson et al., 1999;
McGuire and Nunn, 1999; Shirodaria et al., 2000).
Interleukin-6 is associated with acute phase reactions and
is usually secreted concomitantly with other proinflammatory
cytokines. Some authors relate this cytokine to the destruction of
periodontal tissue by favoring the accumulation of inflammatory
cells and by activating and releasing inflammatory mediators that
in turn accentuate the response to periodontal disease (de Lima
Oliveira et al., 2012; Zhang et al., 2016).
The kinetics of production of IL-18 against the action of
bacteria is rapid, according to its proinflammatory nature. It plays
a central role in systemic and local inflammation (Biet et al.,
2002). One study evaluated IL-18 levels in crevicular gingival
fluid in four groups of patients: healthy periodontium, gingivitis,
chronic periodontitis, and aggressive periodontitis. The results
demonstrated that IL-18 concentration in the crevicular gingival
fluid was low in the group with healthy periodontium
and progressively increased in groups from gingivitis, to
aggressive periodontitis, and finally chronic periodontitis. As the
inflammation increased, there was a concomitant increase in
IL-18 level (Nair et al., 2016). In the current study, treatment with
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monolaurin decreased the IL-18 gene expression in fibroblasts,
however, an opposite result was observed in keratinocytes, where
IL-18 expression was increased in the group treated with 50 µM
monolaurin.
Tumor necrosis factor plays a central role in periodontitis,
being associated with the disease because of its ability to induce
destruction of connective tissue and its effects on bone resorption
through the activation of osteoclasts. Thus, TNF is one of the first
proinflammatory cytokines produced in response to infection by
pathogenic bacteria (Stashenko et al., 1987; de Lima Oliveira et al.,
2012; Zhang et al., 2016). Here, the authors observed a reduction
in the gene expression of TNF in monolaurin treated fibroblasts.
On the other hand, in keratinocytes, TNF expression was higher
in cells treated with 25 µM of this compound. Animal models
challenged with P. gingivalis were treated with antimicrobial
drugs (chlorhexidine, minocycline, and doxycycline) in order to
evaluate its effect on the inflammatory response. Minocycline
induced higher levels of TNF while chlorhexidine reduced TNF
levels, this result led the authors to believe that these agents
modified the inflammatory response to P. gingivalis regardless
of its antimicrobial effect, each in its own way (Houri-Haddad
et al., 2008). Overall, monolaurin modulate the expression of
inflammatory cytokines, suggesting it may have a modulatory
role on the host pro-inflammatory response to help eradicate
the bacterial infection. Similarly, previous studies suggested that
monolaurin play a significant role on T cell functions and
signaling by altering TCR-induced LAT, PLC-γ, and AKT cluster
formation PI3K-AKT signaling axis, and calcium influx which
ultimately decrease the cytokine production (Zhang et al., 2016).
The knowledge of the metabolic profile can contribute to
understanding of the periodontal disease course as well as
identify possible metabolites as biomarkers. This study evaluated
the effects caused by monolaurin on the cellular metabolome
and found significant variations. Relative quantification revealed
lower levels of 2-deoxytetronic acid NIST, 4-aminobutyric acid,
glyceric acid and pinitol, and higher levels of glycerol and
pyruvic acid in cells treated with 25 or 50 µM monolaurin.
Analysis of fibroblast metabolome (HGF) treated with IL-1β in
combination with titanium dioxide nanoparticles (TiO2 NPs),
demonstrated that IL-1β induction reduced concentrations of
primary metabolites, especially those of urea cycle, polyamine,
S-adenosylmethionine and glutathione synthetic pathways. The
addition of TiO2 NPs further increased these metabolic changes
induced by IL-1β. These findings may be useful for the future
establishment of new metabolic markers and therapeutic strategy
for gingival inflammations (Garcia-Contreras et al., 2015). One
study compared the salivary metabolic profile of healthy patients
and patients with periodontal disease. Changes in several classes
of metabolites have been observed in individuals with periodontal
disease. According to the authors, such changes reflected an
increase in host–bacterial interactions in the diseased state
(Barnes et al., 2011).
CONCLUSION
In summary, this study indicates that monolaurin possesses
antimicrobial activity and modulates the host immune response
and modulates production when administered for 24 h in a
dual-chamber model inoculated with A. actinomycetemcomitans.
These findings demonstrate that monolaurin could be considered
a potential candidate for in vivo studies, which may translate
into its potential clinical use to treat pathogenic microbe–host
interactions.
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